News by Subject Medicine & Health

Researchers have discovered that POT1, a gene known to be associated with risk of glioma, the most common type of malignant brain tumor, mediates its effects in a sex-specific manner.

Although current treatments for neurodegenerative disease (ND) help manage symptoms and delay disease progression, they do not offer complete cure and have adverse side effects. Light therapy (LT) has recently caught the attention of neurologists, and ongoing studies have shown some promise for its use in treating ND. In a new article published in Chinese Medical Journal, researchers summarize growing literature on the methods, effectiveness, and applications of LT in treating sleep disorders and ND.

A new algorithm uses online learning to analyze large single-cell data sets using the amount of memory found on a standard laptop computer.

Experts have narrowed the group of individuals with prior allergies who should see an allergist before receiving a COVID-19 vaccine. Allergy evaluation with skin testing prior to COVID-19 vaccination is rarely needed.

A survey of U.S. multiple sclerosis, or MS, specialist clinicians reveals the COVID-19 pandemic has created major changes in how they deliver care. More than 95% of survey respondents reported using telehealth platforms to provide care for their patients. Approximately one half of the respondents were MS specialist neurologists, four out of five of whom indicated that COVID-19 had changed how they were recommending and prescribing MS disease-modifying therapies.

At the current rate of change, it will take more than 200 years for the proportion of women in orthopaedic surgery to reach parity with the overall medical profession, according to a study in Clinical Orthopaedics and Related Research® (CORR®), a publication of The Association of Bone and Joint Surgeons®. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Treating people with Type 2 diabetes with a new once-a-week injectable insulin therapy proved to be safe and as effective as daily insulin injections, according to the results of two international clinical trials published online today in Diabetes Care. The studies suggest that the once-weekly treatment could provide a convenient alternative to the burden of daily insulin shots for diabetes patients.

Postponing procedures during the pandemic sparked anxiety and fear among patients, with many concerned about dying of their conditions before getting surgery.

University of Minnesota Medical School researchers revealed why some glioblastoma patients see exceptional benefits from chemotherapy and survive beyond expectations.